Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T03:05:46.684Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (February 2009)

Published online by Cambridge University Press:  01 August 2009

R. Sutherland
R. Sutherland
Affiliation:
Cancer Research ProgramGarvan Institute of Medical ResearchDarlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 12 , Issue 8 , August 2009 , e14
Copyright
Copyright © Cambridge University Press 2009

References

1.Ang, EZF, Nguyen, HT, Sim, HL, Putti, TC, Lim, LHK. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol Cancer Res 2009; 7: 266–274.CrossRefGoogle ScholarPubMed
2.Beck, AH, Espinosa, I, Edris, B, Li, R, Montgomery, K, Zhu, S, Varma, S, Marinelli, RJ, van de Rijn, M, West, RB. The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res 2009; 15: 778–787.CrossRefGoogle ScholarPubMed
3.Brerner, TM, Jacquemier, J, Charafe-Jauffret, E, Viens, P, Birnbaum, D, Linke, SP. Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients. Int J Cancer 2009; 124: 896–904.CrossRefGoogle Scholar
4.Chlebowski, RT, Kuller, LH, Prentice, RL, Stefanick, ML, Manson, JE, Gass, M, Aragaki, AK, Ockene, JK, Lane, DS, Sarto, GE, Rajkovic, A, Schenken, R, Hendrix, SL, Ravdin, PM, Rohan, TE, Yasmeen, S, Anderson, G. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009; 360: 573–587.CrossRefGoogle ScholarPubMed
5.Connors, SK, Balusu, R, Kundu, CN, Jaiswal, AS, Gairola, CG, Narayan, S. C/EBP β-mediated transcriptional regulation of bcl-xl gene expression in human breast epithelial cells in response to cigarette smoke condensate. Oncogene 2009; 28: 921–932.CrossRefGoogle Scholar
6.de Gonzalez, A, Berg, CD, Visvanathan, K, Robson, M. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst 2009; 101: 205–209.CrossRefGoogle Scholar
7.Ford, CE, Ekstroem, EJ, Andersson, T. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. Proc Natl Acad Sci U S A 2009; 106: 3919–3924.CrossRefGoogle ScholarPubMed
8.Generali, D, Bates, G, Berruti, A, Brizzi, MP, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Dogliotti, L, Banha, AH, Harris, AL, Bottini, A, Fox, SB. Immunomodulation of FOXP3(+) regulatory t cells by the aromatase inhibitor letrozole in breast cancer patients. Clin Cancer Res 2009; 15: 1046–1051.CrossRefGoogle ScholarPubMed
9.Gomes, EM, Rodrigues, MS, Phadke, AP, Butcher, LD, Starling, C, Chen, SL, Chang, DK, Hernandez-Alcoceba, R, Newman, JT, Stone, MJ, Tong, AW. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin Cancer Res 2009; 15: 1317–1325.CrossRefGoogle ScholarPubMed
10.Gonzalez, ME, Li, X, Toy, K, DuPrie, M, Ventura, AC, Banerjee, M, Ljungman, M, Merajver, SD, Kleer, CG. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene 2009; 28: 843–853.CrossRefGoogle ScholarPubMed
11.Guler, G, Huebner, K, Himmetoglu, C, Jimenez, RE, Costinean, S, Volinia, S, Pilarski, RT, Hayran, M, Shapiro, CL. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2 γ expression levels correlate with basal phenotype in breast cancer. Cancer 2009; 115: 899–908.CrossRefGoogle Scholar
12.Holm, C, Kok, M, Michalides, R, Fles, R, Koornstra, RHT, Wesseling, J, Hauptmann, M, Neefjes, J, Peterse, JL, Stal, O, Landberg, G, Linn, SC. Phosphorylation of the oestrogen receptor α at serine 305 and prediction of tamoxifen resistance in breast cancer. J Path 2009; 217: 372–379.CrossRefGoogle ScholarPubMed
13.Hong, SW, Kim, CJ, Park, WS, Shin, JS, Lee, SD, Ko, SG, Jung, SI, Park, IC, An, SK, Lee, WK, Lee, WJ, Jin, DH, Lee, MS. p34(SEI-1) inhibits apoptosis through the stabilization of the x-linked inhibitor of apoptosis protein: p34(SEI-1) as a novel target for anti-breast cancer strategies. Cancer Res 2009; 69: 741–746.CrossRefGoogle ScholarPubMed
14.Hu, M, Peluffo, G, Chen, H, Gelman, R, Schnitt, S, Polyak, K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci U S A 2009; 106: 3372–3377.CrossRefGoogle ScholarPubMed
15.Jin, CY, Yang, YA, Anver, MR, Morris, N, Wang, XC, Zhang, YE. Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. Cancer Res 2009; 69: 735–740.CrossRefGoogle ScholarPubMed
16.Klinakis, A, Szabolcs, M, Chen, GY, Xuan, SH, Hibshoosh, H, Efstratiadis, A. Igf1r as a therapeutic target in a mouse model of basal-like breast cancer. Proc Natl Acad Sci U S A 2009; 106: 2359–2364.CrossRefGoogle Scholar
17.Lee, JY, Kang, MB, Jang, SH, Qian, T, Kim, HJ, Kim, CH, Kim, Y, Kong, G. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 2009; 28: 824–831.CrossRefGoogle ScholarPubMed
18.Lu, J, Tan, M, Huang, WC, Li, P, Guo, H, Tseng, LM, Su, XH, Yang, WT, Treekitkarnmongkol, W, Andreeff, M, Symmans, F, Yu, D. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to taxol resistance. Clin Cancer Res 2009; 15: 1326–1334.CrossRefGoogle ScholarPubMed
19.Malone, JL, Nelson, AC, Lieberman, R, Anderson, S, Holt, JT. Oestrogen-mediated phosphorylation and stabilization of BRCA2 protein in breast. J Path 2009; 217: 380–388.CrossRefGoogle ScholarPubMed
20.McGlynn, LM, Kirkegaard, T, Edwards, J, Tovey, S, Cameron, D, Twelves, C, Bartlett, JMS, Cooke, TG. Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients. Clin Cancer Res 2009; 15: 1487–1495.CrossRefGoogle Scholar
21.Ostrow, KL, Park, HL, Hoque, MO, Kim, MS, Liu, JW, Argani, P, Westra, W, Van Criekinge, W, Sidransky, D. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res 2009; 15: 1184–1191.CrossRefGoogle ScholarPubMed
22.Piening, BD, Wang, P, Subramanian, A, Paulovich, AG. A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients. Radiat Res 2009; 171: 141–154.CrossRefGoogle ScholarPubMed
23.Pylayeva, Y, Gillen, KM, Gerald, W, Beggs, HE, Reichardt, LF, Giancotti, FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009; 119: 252–266.Google ScholarPubMed
24.Ramaswamy, B, Majumder, S, Roy, S, Ghoshal, K, Kutay, H, Datta, J, Younes, M, Shapiro, CL, Motiwala, T, Jacob, ST. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity. Mol Endocrinol 2009; 23: 176–187.CrossRefGoogle ScholarPubMed
25.Sankpal, NV, Willman, MW, Fleming, TP, Mayfield, JD, Gillanders, WE. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 2009; 69: 753–757.Google ScholarPubMed
26.Schild-Hay, LJ, Leil, TA, Divi, RL, Olivero, OA, Weston, A, Poirier, MC. Tamoxifen induces expression of immune response-related genes in cultured normal human mammary epithelial cells. Cancer Res 2009; 69: 1150–1155.CrossRefGoogle ScholarPubMed
27.Sotgia, F, Casimiro, MC, Bonuccelli, G, Liu, MR, Whitaker-Menezes, D, Er, O, Daumer, KM, Mercier, I, Witkiewicz, AK, Minetti, C, Capozza, F, Gormley, M, Quong, AA, Rui, H, Frank, PG, Milliman, JN, Knudsen, ES, Zhou, J, Wang, CG, Pestell, RG, Lisanti, MP. Loss of Caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. Am J Path 2009; 174: 613–629.CrossRefGoogle ScholarPubMed
28.Taylor, IW, Linding, R, Warde-Farley, D, Liu, YM, Pesquita, C, Faria, D, Bull, S, Pawson, T, Morris, Q, Wrana, JL. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009; 27: 199–204.CrossRefGoogle ScholarPubMed
29.Waltersson, MA, Askmalm, MS, Nordenskjold, B, Fornander, T, Skoog, L, Stal, O. Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer. Int J Oncol 2009; 34: 441–448.Google ScholarPubMed
30.Yang, J, Bielenberg, DR, Rodig, SJ, Doiron, R, Clifton, MC, Kung, AL, Strong, RK, Zurakowski, D, Moses, MA. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A 2009; 106: 3913–3918.CrossRefGoogle ScholarPubMed